Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T16:33:03.278Z.
Calculation as of: 2026-10-06T16:33:03.278Z.
Quote observation: 2026-10-06T16:30:41.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 23bdec7124bcf20b562f8235598f93689ea1cbdfcf2aa7384f68a4c8921eaa93
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
Market Cap
$8.77B
EBITDA Yield
N/A
TTM Avg
2.61%
3Y Avg
2.61%
5Y Avg
2.61%
Market Cap
$8.88B
EBITDA Yield
0.71%
TTM Avg
0.48%
3Y Avg
4.02%
5Y Avg
4.02%
Market Cap
$7.93B
EBITDA Yield
2.26%
TTM Avg
2.88%
3Y Avg
2.88%
5Y Avg
2.88%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | $8.58B | N/A | N/A | N/A | N/A |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.77B | N/A | 2.61% | 2.61% | 2.61% |
| Oscar Health, Inc. (OSCR)vs › | $8.42B | 13.66% | 4.45% | 3.74% | 3.74% |
| Protagonist Therapeutics, Inc. (PTGX)vs › | $8.88B | 0.71% | 0.48% | 4.02% | 4.02% |
| Axsome Therapeutics, Inc. (AXSM)vs › | $8.99B | N/A | N/A | N/A | N/A |
| Bruker Corporation (BRKRP)vs › | $9.00B | 3.32% | 0.70% | 0.72% | 0.72% |
| Caris Life Sciences, Inc. (CAI)vs › | $7.93B | 2.26% | 2.88% | 2.88% | 2.88% |
| Bruker Corporation (BRKR)vs › | $9.29B | 3.24% | 4.44% | 4.68% | 4.77% |
| Insulet Corp. (PODD)vs › | $9.39B | 6.33% | 4.06% | 2.63% | 1.89% |
| Praxis Precision Medicines, Inc. (PRAX)vs › | $7.73B | N/A | N/A | N/A | N/A |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
